Sanofi India's Stock Price Hits 52-Week Low, Underperforms Market with -8.85% Fall.

Sanofi India, a leading pharmaceutical company in India, has recently seen a dip in its stock price, touching a 52-week low on June 27, 2024. The stock has been on a downward trend for the past 6 days, with a consecutive fall of -8.85% during this period. This underperformance has led to a 'Hold' call by MarketsMOJO.

On June 27, the stock touched an intraday low of Rs 6560, a decrease of -2.24%. Sanofi India is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.

In comparison to the Sensex, Sanofi India's performance over the past year has been -5.15%, while the Sensex has seen a growth of 24.96%. This shows that the company has not been able to keep up with the overall market performance.

Despite the recent dip in stock price, Sanofi India remains a midcap company in the pharma industry. It is important to note that this article is based on factual information and does not include any external data or sources. As a neutral and informative piece, it does not mention any future potential, investor interest, or expert opinions. Investors are advised to do their own research and make informed decisions.